Bank of Montreal Can Buys 138,739 Shares of Cigna Group $CI

Bank of Montreal Can increased its stake in Cigna Group (NYSE:CI) by 35.1% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 533,564 shares of the health services provider’s stock after purchasing an additional 138,739 shares during the quarter. Bank of Montreal Can owned approximately 0.20% of Cigna Group worth $153,800,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in CI. Pathway Financial Advisers LLC grew its holdings in Cigna Group by 2.3% during the second quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock valued at $496,000 after purchasing an additional 34 shares during the last quarter. Armstrong Advisory Group Inc. lifted its stake in shares of Cigna Group by 17.7% in the third quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock worth $65,000 after buying an additional 34 shares during the last quarter. HM Payson & Co. boosted its holdings in shares of Cigna Group by 0.9% during the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock worth $1,091,000 after buying an additional 35 shares during the period. Carr Financial Group Corp boosted its holdings in shares of Cigna Group by 5.3% during the 3rd quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock worth $204,000 after buying an additional 36 shares during the period. Finally, Natural Investments LLC grew its stake in Cigna Group by 2.0% in the 3rd quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock valued at $531,000 after buying an additional 36 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

NYSE:CI opened at $262.13 on Wednesday. The firm’s 50-day moving average is $280.29 and its 200-day moving average is $283.45. The company has a market cap of $69.08 billion, a price-to-earnings ratio of 11.82, a PEG ratio of 0.93 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business had revenue of $72.50 billion during the quarter, compared to analysts’ expectations of $69.53 billion. During the same quarter last year, the company earned $6.64 earnings per share. The firm’s revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities research analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be given a $1.56 dividend. The ex-dividend date is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.4%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio is 28.13%.

Insider Activity at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares of the company’s stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

CI has been the subject of a number of research analyst reports. Truist Financial boosted their target price on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Piper Sandler lowered their price target on Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Mizuho set a $325.00 price objective on Cigna Group in a research note on Friday, January 9th. Leerink Partners boosted their price objective on Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research report on Friday, February 6th. Finally, Barclays decreased their target price on Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a research note on Friday, February 6th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $330.42.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.